HighTower Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,075
| Closed | -$11K | – | 2381 |
|
|
2019
Q3 | $11K | Sell |
1,075
-2,832
| -72% | -$29K | ﹤0.01% | 2251 |
|
|
2019
Q2 | $68K | Sell |
3,907
-145
| -4% | -$2.52K | ﹤0.01% | 2169 |
|
|
2019
Q1 | $138K | Buy |
4,052
+190
| +5% | +$6.47K | ﹤0.01% | 2009 |
|
|
2018
Q4 | $109K | Sell |
3,862
-1,840
| -32% | -$51.9K | ﹤0.01% | 1939 |
|
|
2018
Q3 | $348K | Sell |
5,702
-573
| -9% | -$35K | ﹤0.01% | 1649 |
|
|
2018
Q2 | $464K | Buy |
6,275
+564
| +10% | +$41.7K | ﹤0.01% | 1483 |
|
|
2018
Q1 | $375K | Buy |
5,711
+1,906
| +50% | +$125K | ﹤0.01% | 1564 |
|
|
2017
Q4 | $316K | Buy |
3,805
+135
| +4% | +$11.2K | ﹤0.01% | 1678 |
|
|
2017
Q3 | $430K | Sell |
3,670
-131
| -3% | -$15.3K | ﹤0.01% | 1504 |
|
|
2017
Q2 | $448K | Buy |
+3,801
| New | +$448K | ﹤0.01% | 1423 |
|